Completed PHASE4 INTERVENTIONAL 4-arm NCT01159652

Hypnotic Medications and Memory: Effect of Drug Exposure During the Night

Hypnotic Medications and Sleep-dependent Memory Consolidation: the Effect of Variable Drug Exposure During the Night

Sponsor: American Academy of Sleep Medicine

Interventions bedtime placebo middle of the night placebo zaleplon zolpidem extended release

Updated 5 times since 2017 Last updated: Aug 25, 2014 Started: Oct 31, 2010 Primary completion: May 31, 2011 Completion: May 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01159652, this PHASE4 trial focuses on Memory and Sleep and remains completed. Sponsored by American Academy of Sleep Medicine, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Academy of Sleep Medicine
St. Luke's Hospital, Chesterfield, Missouri

Data source: St. Luke's Hospital, Chesterfield, Missouri

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chesterfield, United States